Loading the security page…
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Fulgent Genetics, Inc. (FLGT) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Fulgent Genetics, Inc. (FLGT) on October 30, 2026 is 20.67 $, −4.66 % on the day. Over 52 weeks the stock traded between 13.46 $ and 31.04 $; the price now sits 41 % of the way up that range. Over the past year the price changed by −6.16 %. Market capitalization is 568.74 million $, rank 16 among 24 stocks of the same industry with a known capitalization.
Fulgent Genetics, Inc. trades on Nasdaq under the ticker FLGT. The company belongs to the Health care sector. The trading history on this page starts on 29 September 2016.
Over the past 52 weeks FLGT has traded between 13.46 $ and 31.04 $. As of 30 October 2026 the price stood 42.95 % of the way from the 52-week low to the high.
Over one year FLGT shares fell 6.16 %; over six months they rose 29.93 %. Volatility over 90 days is 49.68 %. Dividends are not included: this is price change only, as of 30 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 1.8, below the sector median of 3.6. Price to book is 0.6, below the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
Fulgent Genetics, Inc. reported revenue of 324M $ and a net loss of 84M $ over the last four quarters. Net margin is −26.05 %. Revenue changed by +6.83 % year over year. Earnings per share are −2.83 $. Market capitalisation is 569M $.
FLGT has a return on equity of −8.42 %, above the sector median of −40.58 %. Return on assets is −7.75 %, above the sector median of −30.08 %. Operating margin is −37.75 %, below the sector median of −20.96 %.